Osmigen 80mg Tablets

Introduction to Osmigen 80mg

Osmigen 80mg, manufactured by General Pharmaceuticals Ltd., contains Osimertinib, a third-generation EGFR tyrosine kinase inhibitor. It is formulated for the treatment of non-small cell lung cancer (NSCLC) in patients with certain EGFR mutations. Osmigen 80mg helps stop the growth of cancer cells by blocking abnormal EGFR protein activity, slowing down the progression of the disease.

This medication is often prescribed as a first-line treatment for metastatic NSCLC or for patients whose cancer has become immune to earlier EGFR-targeted therapies. Always take Osmigen 80mg as directed by the patient's healthcare provider.